| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.23B | 4.92B | 4.27B | 3.79B | 3.14B | 2.68B |
| Gross Profit | 974.86M | 1.34B | 970.99M | 1.10B | 782.27M | 791.00M |
| EBITDA | 1.82B | 2.07B | 1.87B | 1.86B | 1.40B | 1.04B |
| Net Income | -114.63M | -146.05M | -24.77M | 210.13M | 144.33M | 204.63M |
Balance Sheet | ||||||
| Total Assets | 12.77B | 11.43B | 12.96B | 9.39B | 7.29B | 5.66B |
| Cash, Cash Equivalents and Short-Term Investments | 1.39B | 882.00M | 3.18B | 937.90M | 679.82M | 750.35M |
| Total Debt | 9.11B | 7.69B | 9.60B | 5.84B | 4.25B | 2.91B |
| Total Liabilities | 9.94B | 8.46B | 9.98B | 6.36B | 4.50B | 3.26B |
| Stockholders Equity | 2.83B | 2.97B | 2.98B | 3.03B | 2.79B | 2.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.26B | -1.50B | -1.38B | -1.64B | -333.50M |
| Operating Cash Flow | 0.00 | 1.75B | 1.48B | 1.73B | 918.35M | 880.83M |
| Investing Cash Flow | 0.00 | -1.99B | -2.96B | -3.11B | -2.56B | -824.11M |
| Financing Cash Flow | 0.00 | -2.09B | 3.72B | 1.64B | 1.59B | 205.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.82B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
76 Outperform | ¥14.51B | 8.19 | ― | 3.03% | 6.36% | 41.53% | |
65 Neutral | ¥1.15T | 8.84 | ― | 3.37% | 6.51% | 30.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | ¥392.48B | 17.81 | ― | 3.62% | 16.26% | -52.33% | |
44 Neutral | ¥5.14B | -41.81 | ― | 0.38% | 15.21% | -489.73% |